免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

奈諾檢流感A+B檢測試劑

K 號:K252283 · 2026-01-15

決定日期2026-01-15
產品代碼PSZ
諮詢委員會MI (請提供完整的描述文本,以便進行翻譯。)
決定相當於

器材摘要

Nano-Check Influenza A+B Test is the device name listed in this FDA 510(k) record. The listed applicant is Nano-Ditech Corporation. It received FDA 510(k) clearance on 2026-01-15 under 510(k) number K252283. The device is classified under product code PSZ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Nano-Check Influenza A+B Test?

Nano-Check Influenza A+B Test is a medical device that received FDA 510(k) clearance on 2026-01-15. The listed applicant is Nano-Ditech Corporation. The 510(k) number is K252283.

When did Nano-Check Influenza A+B Test receive FDA 510(k) clearance?

Nano-Check Influenza A+B Test received FDA 510(k) clearance on 2026-01-15, under 510(k) number K252283.

Who is the listed applicant for Nano-Check Influenza A+B Test?

The FDA 510(k) record lists Nano-Ditech Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Nano-Check Influenza A+B Test?

The FDA product code for Nano-Check Influenza A+B Test is PSZ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Nano-Ditech Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:PSZ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑